Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexibuprofen versus ibuprofen oral suspension for painful hip or knee osteoarthritis
2009-010719-33Phase 3Completed
- Sponsor
- Gebro Pharma
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexibuprofen and ibuprofen in hip osteoarthritis and knee osteoarthritis (OA) (2 arms), sponsored by Gebro Pharma. Primary endpoint: Safety and tolerability based on gastrointestinal drug-related adverse events. Started Apr 2009; status: completed.
02
Drugs
dexibuprofenibuprofen
03
Conditions
hip osteoarthritisknee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-010719-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010719-33.